Pancreatitis Trial, Recruiting NCT06267365 Sponsor: NYU Langone Health Condition: Pancreatitis
Back to Pancreatitis

Pancreatitis Trial, Recruiting

NCT06267365
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You have been diagnosed with chronic pancreatitis based on specific medical criteria (Cambridge III or IV, or M-ANNHEIM definitive criteria — confirm with trial site if unsure which applies to you)
  • You are already scheduled to receive an endoscopy-based procedure to help unblock your pancreatic duct as part of your regular medical care (this may include breaking up or removing stones, or widening the duct to allow placement of a small tube called a stent)
  • You have had pain on 3 or more days per week for at least 3 months
  • Your average pain level over the past week has been at least 4 out of 10 on a pain scale

Who may not be able to join:

  • You have a long-term pain condition other than chronic pancreatitis
  • You have had a flare-up of acute (sudden, severe) pancreatitis within the last 2 months
  • You have had a scope-based procedure (such as ERCP or a nerve-blocking procedure near the pancreas) or pancreatic surgery within the last 6 months
  • You are currently using illegal drugs (marijuana use is not excluded)
  • You have been assessed by an anesthesiologist as being at high medical risk for procedures (confirm with trial site)
  • Your pancreatitis is caused by your immune system, or you have a tumor or growth affecting your pancreas
  • You have a major neurological condition such as a stroke, epilepsy that is not well controlled, or dementia
  • You have been diagnosed with schizophrenia
  • You regularly take benzodiazepines (a type of anti-anxiety or sleep medication) — note that occasional, short-acting use may be acceptable as long as you can pause taking them before a brain wave (EEG) recording
  • You are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tamas Gonda, MD, NYU Langone Health

Phone: 212-263-5072

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
27 November 2023
Est. completion
1 March 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change from Baseline in Brief Pain Inventory (BPI) Score at Month 3 Post-Operation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov